跳至主要内容
临床试验/NCT05431517
NCT05431517已完成不适用

Incidence, Risk Factors and Endoscopic Retrieval of Proximally Migrated Pancreatic Stents: 25 Years of Experience in a Tertiary Center

Changhai Hospital1 个研究点 分布在 1 个国家目标入组 9,073 人开始时间: 2022年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
9,073
试验地点
1
主要终点
Incidence of proximally migrated pancreatic stents

研究概览

简要总结

This study intends to determine the incidence, risk factors and endoscopic treatment of proximally migrated pancreatic stents.

详细描述

Endoscopic pancreatic stenting can be used to treat a variety of pancreatic disorders, including chronic pancreatitis-induced pancreatic duct stenosis, pancreatic schizophrenia, pancreatic leakage, pancreatic pseudocyst drainage, and prophylactic pancreatic duct stenting. Postoperative stent migration is one of the complications associated with pancreatic stent placement.

In this retrospective study, more than 9,000 Endoscopic retrograde cholangiopancreatography (ERCP) cases at our center over the past 25 years will be analyzed to determine the incidence, risk factors and endoscopic treatment of proximally migrated pancreatic stents.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Pancreatic stent placement under ERCP;
  • Pancreatic stent migration found by ERCP;
  • Displaced pancreatic stent removal by ERCP technique.

排除标准

  • Incomplete ERCP records (e.g., missing stent size information);
  • Immediate removal of pancreatic stent following implantation for a variety of reasons.

结局指标

主要结局

Incidence of proximally migrated pancreatic stents

时间窗: Within 1 month after data analysis

Success rate of endoscopic removal of migrated pancreatic stents

时间窗: Within 1 month after data analysis

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhaoshen Li

Professor

Changhai Hospital

研究点 (1)

Loading locations...

相似试验